Urine markers of interstitial cystitis (Q43621219)

25 November 2017

title

Urine markers of interstitial cystitis (English)

1 reference

25 November 2017

Erickson DR

1

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

57

1 reference

25 November 2017

issue

6 Suppl 1

1 reference

25 November 2017

page(s)

15-21

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

25 November 2017

1 reference

7 January 2021

The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

A diagnostic in vitro urine assay for interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Decreased urinary uronic acid levels in individuals with interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Glycosaminoglycans excretion in interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Urinary epitectin (MUC-1 glycoprotein) in the menstrual cycle and interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Increased urinary hyaluronic acid and interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Increased urine histamine and methylhistamine in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Urine eosinophil cationic protein in painful bladder disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Chronic interstitial cystitis: increased levels of eosinophil cationic protein in serum and urine and an ameliorating effect of subcutaneous heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Complement C3, eosinophil cationic protein and symptom evaluation in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Elevated mast cell tryptase in the urine of patients with interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Interleukin-6 and interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette-Guérin treat interstitial cystitis by altering the immune profile in the bladder?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Inflammatory mediator profile in urine and bladder wash fluid of patients with interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Effect of long-term oral L-arginine on the nitric oxide synthase pathway in the urine from patients with interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Activation of urinary kallikrein in patients with interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

ACTIVATION OF THE KALLIKREIN KININ SYSTEM IN INTERSTITIAL CYSTITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Urine autoantibodies in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Elevated urinary norepinephrine in interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

PENTOSANPOLYSULFATE INHIBITS MAST CELL HISTAMINE SECRETION AND INTRACELLULAR CALCIUM ION LEVELS:: AN ALTERNATIVE EXPLANATION OF ITS BENEFICIAL EFFECT IN INTERSTITIAL CYSTITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Interstitial cystitis: a neuroimmunoendocrine disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

Urinary neutrophil chemotactic factors in interstitial cystitis patients and a rabbit model of bladder inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901128-1

7 January 2021

10.1016/S0090-4295(01)01128-1

Identifiers

DOI

1 reference

25 November 2017

1 reference